SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-180487
Filing Date
2018-05-31
Accepted
2018-05-31 17:08:02
Documents
1
Group Members
KEVIN FERROVATERA HEALTHCARE PARTNERS LLCVHPM HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A (AMENDMENT NO. 3) d558616dsc13da.htm SC 13D/A 78397
  Complete submission text file 0001193125-18-180487.txt   80183
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 18872452
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212-590-2950
VATERA HOLDINGS LLC (Filed by) CIK: 0001548880 (see all company filings)

IRS No.: 208894647 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A